Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1535070 | 0.79 | LPL (0.41) | LPLLIPGP2RX7MAPK1F11 | |
| SCHEMBL27111331 | 0.74 | LPL (0.33) | LPLLIPGP2RX7MAPK1F11 | |
| SCHEMBL25172768 | 0.74 | LPL (0.33) | LPLLIPGP2RX7MAPK1FFAR1 | |
| SCHEMBL21295651 | 0.73 | LPL (0.38) | LPLLIPG | |
| SCHEMBL20272142 | 0.72 | LPL (0.37) | LPLLIPGP2RX7MAPK1FFAR1 | |
| SCHEMBL19038812 | 0.71 | LPL (0.40) | LPLLIPGF11FFAR1CA1 | |
| SCHEMBL2363814 | 0.71 | LPL (0.40) | LPLLIPGF11FFAR1CA1 | |
| SCHEMBL20305251 | 0.71 | LPL (0.35) | LPLLIPGP2RX7MAPK1F11 | |
| SCHEMBL900563 | 0.70 | LPL (0.31) | LPLLIPGP2RX7FFAR1 | |
| SCHEMBL30881090 | 0.69 | DGAT1 (0.33) | LPLLIPGP2RX7F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240147840-A1 | SPIROFLUORENE SILICON COMPOUND AND ELECTROLUMINESCENCE USING THE SAME | Shanghai Tianma Micro-electronics Co., Ltd. (CN) | 2024-05-02 | — | — | US | disclosed |
| CN-109312230-B | Compound for organic photoelectric device, composition for organic photoelectric device, and display device | 三星SDI株式会社 | 2021-12-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240147840-A1 | SPIROFLUORENE SILICON COMPOUND AND ELECTROLUMINESCENCE USING THE SAME | AR, NR3C2, RPS3A | LPL 4193/4885LIPG 4665/4885P2RX7 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.